174 related articles for article (PubMed ID: 37496053)
1. MFNG is an independent prognostic marker for osteosarcoma.
Gao Y; Luo L; Qu Y; Zhou Q
Eur J Med Res; 2023 Jul; 28(1):256. PubMed ID: 37496053
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
4. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-related genes-based prognostic signature for osteosarcoma.
Yang F; Zhang Y
Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
[TBL] [Abstract][Full Text] [Related]
6. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
[TBL] [Abstract][Full Text] [Related]
7. Nuclear and stromal expression of Manic fringe in renal cell carcinoma.
Cheng WK; Kaur G; Sjöberg E; Frödin M; Egevad L; Harmenberg U; Li JL; Oon CE
Exp Mol Pathol; 2021 Oct; 122():104667. PubMed ID: 34371013
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.
Shi X; Guan X
Diagn Pathol; 2019 Oct; 14(1):117. PubMed ID: 31651329
[TBL] [Abstract][Full Text] [Related]
9. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma.
Lian H; Zhou Y; Sun Z; Liu K
Medicine (Baltimore); 2022 Sep; 101(38):e30722. PubMed ID: 36197268
[TBL] [Abstract][Full Text] [Related]
11. LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway.
Yao Q; Chen T
J Cell Mol Med; 2020 Dec; 24(24):14293-14305. PubMed ID: 33108067
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma.
Jin Y; Li L; Zhu T; Liu G
Pathol Res Pract; 2019 Dec; 215(12):152688. PubMed ID: 31727503
[TBL] [Abstract][Full Text] [Related]
15. MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration.
Du X; Zhang Q; Wang S; Chen X; Wang Y
J Clin Lab Anal; 2022 Feb; 36(2):e24214. PubMed ID: 34961985
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
Li F; Cao L; Hang D; Wang F; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
[TBL] [Abstract][Full Text] [Related]
19. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
[TBL] [Abstract][Full Text] [Related]
20. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]